Epitope Analysis of Anti-Myeloperoxidase Antibodies in Patients with ANCA-Associated Vasculitis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Gou, Shen Ju ^a   Xu, Peng Cheng ^a   Chen, Min ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; EPITOPE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RECOMBINANT PROTEIN;

ADULT; ANCA ASSOCIATED VASCULITIS; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS REACTION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN PURIFICATION; RELAPSE; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES; CROSS REACTIONS; EPITOPE MAPPING; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEROXIDASE; RECOMBINANT PROTEINS; RECURRENCE; SEQUENCE DELETION; YOUNG ADULT;

EID: 84875963150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060530     Document Type: Article

References (33)

1. Falk RJ, Jennette JC, (1997) ANCA small-vessel vasculitis. J Am Soc Nephrol 8: 314-322.
2. Chen M, Yu F, Zhang Y, Zhao MH, (2005) Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre. Postgrad Med J 81: 723-727.
3. Chen M, Yu F, Zhang Y, Zhao MH, (2008) Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore) 87: 203-209.
4. Chen M, Cui Z, Zhao MH, (2010) ANCA-associated vasculitis and anti-GBM disease: the experience in China. Nephrol Dial Transplant 25: 2062-2065.
5. Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, et al. (2005) Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 68: 2225-2229.
6. Chen M, Yu F, Wang SX, Zou WZ, Zhang Y, et al. (2007) Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis. Nephrol Dial Transplant 22: 139-145.
7. Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C, (1997) Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 8: 376-385.
8. Short AK, Esnault VL, Lockwood CM, (1995) Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis 26: 439-445.
9. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, et al. (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955-963.
10. Bansal PJ, Tobin MC, (2004) Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93: 398-401.
11. Falk RJ, Terrell RS, Charles LA, Jennette JC, (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87: 4115-4119.
12. Holland M, Hewins P, Goodall M, Adu D, Jefferis R, et al. (2004) Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol 138: 183-192.
13. Kokolina E, Noel LH, Nusbaum P, Geffriaud C, Grunfeld JP, et al. (1994) Isotype and affinity of anti-myeloperoxidase autoantibodies in systemic vasculitis. Kidney Int 46: 177-184.
14. Ye H, Zhao MH, Gao Y, Guo XH, Wang HY, (2004) Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule. Clin Exp Immunol 138: 179-182.
15. Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Nakabayashi K, et al. (1993) Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol 40: 256-264.
16. Pankhurst T, Nash G, Williams J, Colman R, Hussain A, et al. (2011) Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgG. Clin Exp Immunol 164: 218-226.
17. Birck R, Schmitt WH, Kaelsch IA, Van der Woude FJ, (2006) Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review. Am J Kidney Dis 47: 15-23.
18. Lin W, Chen M, Zhao MH, (2009) Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis. Autoimmunity 42: 198-202.
19. Liu LJ, Chen M, Yu F, Zhao MH, Wang HY, (2008) IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis. Nephrology (Carlton) 13: 629-635.
20. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192.
21. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33: 1101-1107.
22. Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, et al. (2007) EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66: 605-617.
23. Zhao MH, Lockwood CM, (1996) A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods 197: 121-130.
24. Cui Z, Zhao MH, Xin G, Wang HY, (2005) Characteristics and prognosis of Chinese patients with anti-glomerular basement membrane disease. Nephron Clin Pract 99: c49-55.
25. Locke IC, Leaker B, Cambridge G, (1999) A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions. Clin Exp Immunol 115: 369-376.
26. Erdbrugger U, Hellmark T, Bunch DO, Alcorta DA, Jennette JC, et al. (2006) Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers. Kidney Int 69: 1799-1805.
27. Fujieda M, Suzuki K, Sato H, Hattori M, Wada N, et al. (2005) Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil. Clin Nephrol 63: 437-445.
28. Suzuki K, Kobayashi S, Yamazaki K, Gondo M, Tomizawa K, et al. (2007) Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population. Microbiol Immunol 51: 1215-1220.
29. Hansson M, Olsson I, Nauseef WM, (2006) Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 445: 214-224.
30. Tomizawa K, Mine E, Fujii A, Ohashi YY, Yamagoe S, et al. (1998) A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants. J Clin Immunol 18: 142-152.
31. Bruner BF, Vista ES, Wynn DM, James JA, (2011) Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes. Clin Exp Immunol 164: 330-336.
32. Zeng J, Fenna RE, (1992) X-ray crystal structure of canine myeloperoxidase at 3 A resolution. J Mol Biol 226: 185-207.
33. Chen J, Anderson JB, DeWeese-Scott C, Fedorova ND, Geer LY, et al. (2003) MMDB: Entrez's 3D-structure database. Nucleic Acids Res 31: 474-477.